> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Rezolute's CEO Took Home $5,711,410 And Also Chairs The Board, Proxy Shows
- URL: https://www.bullished.co/rezolutes-ceo-took-home-5-711-410-and-also-chairs-the-board-proxy-shows-61925309/
- Published: 2026-10-22T12:31:52.000Z
- Updated: 2026-11-05T20:27:29.000Z
- Description: The annual proxy lists Nevan Elam as CEO and acting chairman, with a vote on more authorized shares set for December 2.
- Author: Matteo Parrino
- Tags: SEC Filings, RZLT, Industry: Healthcare, Topic: Leadership & Governance

Rezolute CEO Nevan Charles Elam received [$5,711,410 in total compensation](https://www.sec.gov/Archives/edgar/data/0001509261/000110465926117868/rzlt-20261202xdef14a.htm?ref=bullished.co), according to the pay table in the company's annual proxy filing dated Wednesday. The same filing shows he is also acting chairman of the board, while stockholders are asked to approve an increase in authorized shares.

## One person, two seats

Elam has been CEO since January 2013 and acting chair of the board since May 2022, the proxy says. Young-Jin Kim, who now sits as a director, chaired the board until May 2022.

The board says it has no policy on whether one person should hold both the CEO and chairman jobs. It says it wants flexibility to decide "at any given point in time" what provides appropriate leadership.

There are seven directors, and five are independent under Nasdaq rules. Elam and Kim are the two who are not. Kim is Chairman and CEO of Handok, a pharmaceutical company in Korea, and the board has one observer, So-Hyun Kwon, a representative of Handok.

## The ballot

Stockholders vote at a virtual annual meeting on Wednesday, December 2, 2026, at 3:00 p.m. Pacific Time. All seven directors are nominated for re-election, and the proxy says no stockholder has nominated anyone.

The ballot also carries the shareholder vote on executive pay, the Share Increase Proposal (Proposal 4) and an Adjournment Proposal (Proposal 5). Management recommends the share increase and adjournment items. The share increase is the item that changes what each existing share represents.

The proxy also covers the auditor ratification as Proposal 2.

## How the board worked

The board met seven times in the fiscal year ended June 30, 2026, and every director attended at least 75% of the meetings of the board and the committees they served on. The audit committee met four times and the compensation committee three times.

Gil Labrucherie chairs the audit committee. Wladimir Hogenhuis, M.D., chairs the compensation committee, and Nerissa Kreher, M.D., chairs the nominating and governance committee.

Voting runs through the December 2 meeting, where the share increase and the re-election of a CEO who also leads the board are on the same ballot.

Learn

- [A Checklist For Reading A Proxy Statement's Executive Pay Table →](https://www.bullished.co/learn/how-to-read-proxy-statement-executive-compensation/)  
Read a proxy statement's executive pay in six steps: summary table, pay ratio, perks, related-party deals, activist settlements and votes, with real examples.
- [What Is A Proxy Fight? How Nominations, Board Letters And The Vote Work →](https://www.bullished.co/learn/what-is-a-proxy-fight/)  
A proxy fight is a contested shareholder vote, usually over board seats. See how nominations, board letters and the ballot work, with a live Vail Resorts example.

### Sources

- [Rezolute — DEF 14A (2026-10-21)](https://www.sec.gov/Archives/edgar/data/0001509261/000110465926117868/rzlt-20261202xdef14a.htm?ref=bullished.co) — SEC EDGAR

### More on Rezolute

- [Rezolute Sizes Tumor Hyperinsulinism At $4-5 Billion, With Patients Needing Triple The Vials](https://www.bullished.co/rezolute-sizes-tumor-hyperinsulinism-at-4-5-billion-with-patients-needing-triple-the-vials-c8adbb53/)
- [Jennison Associates Takes A 5.5% Passive Stake In Rezolute, Holding 5.3 Million Shares](https://www.bullished.co/jennison-associates-takes-a-5-5-passive-stake-in-rezolute-holding-5-3-million-shares-2ac28d6a/)
- [Rezolute Finishes Enrolling 16-Patient Tumor Hyperinsulinism Trial, Expects Topline Data Mid-December](https://www.bullished.co/rezolute-finishes-enrolling-16-patient-tumor-hyperinsulinism-trial-expects-topline-data-5dc3335f/)

[All Rezolute (RZLT) coverage →](https://www.bullished.co/tag/rzlt/)